ClinicalTrials.Veeva

Menu

Chinese Research Group of Gallbladder Cancer (CRGGC)

S

Shanghai Jiao Tong University School of Medicine

Status

Enrolling

Conditions

Gallbladder Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT04140552
CRGGC_LYB_2019

Details and patient eligibility

About

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

Full description

The objectives of the CRGGC are as follows:

  1. To study the current diagnosis and treatment of gallbladder cancer in China.
  2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
  3. To improve the accurate staging of gallbladder cancer.
  4. To standardize the treatment with gallbladder cancer.

Enrollment

10,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
  • Patients with accessible electronic medical record

Exclusion criteria

  • Patients with undetermined primary site of cancer.

Trial contacts and locations

55

Loading...

Central trial contact

Yingbin Liu, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems